Webinars » Lentivirus vector manufacturing using suspension cell line

Lentivirus vector manufacturing using suspension cell line

Gene and cell therapy has made a great breakthrough in the recent years, however the industry is facing challenges in developing stable and scalable manufacturing process for viral vectors. ProBio is dedicated in developing platforms to produce viral vectors, and currently it has robust viral vector manufacturing processes using both adherent culture and suspension culture. ProBio has vast experience in assisting several customers to submit IND to FDA and NMPA, and supporting manufacturing for clinical phase use.

In this webinar, we will cover

Challenges in process development of viral vector

Viral vector manufacturing using adherent and suspension platforms

enScript ProBio track record

In this webinar, you will learn

Webinar Details

  • Date: 11th Mar 2021
  • Time: 10:00 AM SGT
  • Speaker:
Dr. Mahmood Ali Dr. Mahmood Ali

Project Manager of Virus(R&D) Purification Process

Dr. Mahmood Ali is a sought after Gene Therapy expert worldwide. After getting his M.D in Imaging and Molecular Biology from China and CME for Genetics from the States, he entered the Gene and cell therapy industry to explore his passion for eliminating genetic diseases. He has completed a number of Lentivirus and AAV production batches and has deep understanding and experience in the production process.

Related services and products

Plasmid CDMO service

  • Different quality levels and quantity options available to follow the gene and cell therapy development process.

Learn More
Viral vector CDMO service

  • One-stop lentivirus solutions, enables smooth transition from preclinical, through clinical to commercialization.

Learn More

Speaker-related Webinars

Latest Webinars

Find More Biologics Categories »

Development of Cell-Based Functional Assay with High Efficiency

Development of Cell-Based Functional Assay with High Efficiency

Molecular Classification-based identification of diagnostic and treatment targets in glioma

Molecular Classification-based identification of diagnostic and treatment targets in glioma

High-Quality Plasmid DNA Manufacturing Strategies for Gene and Cell Therapeutics

High-Quality Plasmid DNA Manufacturing Strategies for Gene and Cell Therapeutics